Shanghai Xuerong Bio-Technology Co Ltd Cash Flow Conversion Efficiency
Shanghai Xuerong Bio-Technology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Xuerong Bio-Technology Co Ltd (300511) has a cash flow conversion efficiency ratio of -0.036x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-62.35 Million ≈ $-9.12 Million USD) by net assets (CN¥1.71 Billion ≈ $250.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
Cash flow conversion efficiency of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. This chart illustrates how Shanghai Xuerong Bio-Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Shanghai Xuerong Bio-Technology Co Ltd (300511) share price today for real-time trading data and today's change.
Shanghai Xuerong Bio-Technology Co Ltd Cash Flow Conversion Ratio Explained
Shanghai Xuerong Bio-Technology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Shanghai Xuerong Bio-Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shanghai Xuerong Bio-Technology Co Ltd ranked by their cash flow conversion efficiency. Also see Shanghai Xuerong Bio-Technology Co Ltd market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
STL Technology Co Ltd
TWO:4931
|
0.090x |
|
Guangdong Jinming Machinery Co Ltd
SHE:300281
|
0.013x |
|
Sysgration Ltd
TWO:5309
|
-0.013x |
|
China Datang Corporation Renewable Power Co. Limited
STU:DT7
|
0.046x |
|
ZheJiang Haers Vacuum Containers Co Ltd
SHE:002615
|
0.076x |
|
Autolus Therapeutics Ltd
NASDAQ:AUTL
|
-0.335x |
|
Ideal United Bintang Bhd
KLSE:9687
|
0.012x |
|
Gazit Globe Ltd
TA:GZT
|
0.007x |
Annual Cash Flow Conversion Efficiency for Shanghai Xuerong Bio-Technology Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Shanghai Xuerong Bio-Technology Co Ltd from 2012 to 2024. Review free cash flow generation of Shanghai Xuerong Bio-Technology Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥823.32 Million ≈ $120.48 Million |
CN¥437.20 Million ≈ $63.98 Million |
0.531x | +112.56% |
| 2023-12-31 | CN¥1.43 Billion ≈ $209.60 Million |
CN¥357.84 Million ≈ $52.36 Million |
0.250x | +10.63% |
| 2022-12-31 | CN¥1.63 Billion ≈ $237.91 Million |
CN¥367.13 Million ≈ $53.72 Million |
0.226x | +51.42% |
| 2021-12-31 | CN¥1.65 Billion ≈ $242.11 Million |
CN¥246.75 Million ≈ $36.11 Million |
0.149x | -45.69% |
| 2020-12-31 | CN¥2.02 Billion ≈ $296.00 Million |
CN¥555.47 Million ≈ $81.28 Million |
0.275x | -18.60% |
| 2019-12-31 | CN¥1.74 Billion ≈ $254.60 Million |
CN¥586.93 Million ≈ $85.89 Million |
0.337x | +30.18% |
| 2018-12-31 | CN¥1.57 Billion ≈ $229.73 Million |
CN¥406.82 Million ≈ $59.53 Million |
0.259x | +11.68% |
| 2017-12-31 | CN¥1.42 Billion ≈ $207.26 Million |
CN¥328.64 Million ≈ $48.09 Million |
0.232x | -5.80% |
| 2016-12-31 | CN¥1.29 Billion ≈ $188.75 Million |
CN¥317.71 Million ≈ $46.49 Million |
0.246x | -42.15% |
| 2015-12-31 | CN¥642.99 Million ≈ $94.09 Million |
CN¥273.77 Million ≈ $40.06 Million |
0.426x | -11.06% |
| 2014-12-31 | CN¥529.00 Million ≈ $77.41 Million |
CN¥253.24 Million ≈ $37.06 Million |
0.479x | -11.72% |
| 2013-12-31 | CN¥433.49 Million ≈ $63.43 Million |
CN¥235.07 Million ≈ $34.40 Million |
0.542x | +84.31% |
| 2012-12-31 | CN¥381.15 Million ≈ $55.77 Million |
CN¥112.14 Million ≈ $16.41 Million |
0.294x | -- |
About Shanghai Xuerong Bio-Technology Co Ltd
Shanghai Xuerong Biotechnology Co.,Ltd., together with its subsidiaries, engages in the research and development, cultivation and sale of fresh edible mushrooms in the People's Republic of China. It offers enoki mushrooms; shiitake mushrooms, including oyster mushrooms, white jade mushrooms and seafood mushrooms; king oyster mushrooms; and velvet mushrooms, as well as Pleurotus eryngii and Flammu… Read more